<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(4)</volume><submitter>Hu G</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Systemic inflammatory response (SIR) plays important roles in initiation, promotion and progression of tumor. However, the prognostic role of baseline circulating platelet-to-lymphocyte ratio (PLR) (known as a marker of SIR) in human initial stage Ⅳ gastric cancer (GC) remains controversial. Hence, we performed this meta-analysis to assess the value of it in prognosis prediction for these patients.&lt;h4>Materials and methods&lt;/h4>We searched PubMed, Embase and EBSCO to identify the studies and computed extracted data with STATA 12.0.&lt;h4>Results&lt;/h4>A total of 3025 patients with initial stage Ⅳ GC from 13 published studies were incorporated into this meta-analysis. We found that elevated baseline circulating PLR was significantly associated with decreased overall survival (O</pubmed_abstract><journal>PloS one</journal><pagination>e0265897</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9015147</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Elevated baseline circulating platelet-to-lymphocyte ratio and survival in initial stage Ⅳ gastric cancer patients: A meta-analysis.</pubmed_title><pmcid>PMC9015147</pmcid><pubmed_authors>Hu G</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Huang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elevated baseline circulating platelet-to-lymphocyte ratio and survival in initial stage Ⅳ gastric cancer patients: A meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Systemic inflammatory response (SIR) plays important roles in initiation, promotion and progression of tumor. However, the prognostic role of baseline circulating platelet-to-lymphocyte ratio (PLR) (known as a marker of SIR) in human initial stage Ⅳ gastric cancer (GC) remains controversial. Hence, we performed this meta-analysis to assess the value of it in prognosis prediction for these patients.&lt;h4>Materials and methods&lt;/h4>We searched PubMed, Embase and EBSCO to identify the studies and computed extracted data with STATA 12.0.&lt;h4>Results&lt;/h4>A total of 3025 patients with initial stage Ⅳ GC from 13 published studies were incorporated into this meta-analysis. We found that elevated baseline circulating PLR was significantly associated with decreased overall survival (O</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T20:37:02.565Z</modification><creation>2025-04-04T20:37:02.565Z</creation></dates><accession>S-EPMC9015147</accession><cross_references><pubmed>35436305</pubmed><doi>10.1371/journal.pone.0265897</doi></cross_references></HashMap>